newsfilter
← Latest News
CNBC·

Healthy Returns: Pfizer’s new obesity bet, Metsera, releases encouraging data on lead drug

Metsera released data from mid-stage trials on its lead obesity drug candidate, while a high stakes Medicare open enrollment approaches.